Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Temsirolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Clofazimine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/16/2021 3 0
Tilorone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 3 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 4 0